Cannabis & Psychedelics On the 2024 Ballot
The DEA Is Knocking at Your Door . . . Are You Prepared? – Diagnosing Health Care
Podcast - DEA Plants the Seed for Rescheduling Marijuana: What's Next?
The Presumption of Innocence Podcast: Special Edition | Episode 36 - Rolling Change: The DEA Turns Over a New Leaf on Marijuana Scheduling
Cannabis Law Now Podcast: The ‘CannaBoies' Lawsuit and Why it Matters
Law of the Land? Cannabis, Preemption, and SCOTUS [More with McGlinchey Ep. 37]
Understanding the Psychedelics Renaissance Podcast
[Podcast] Virginia Seeks to Become the Next State to Decriminalize Possession of Psychedelic Mushrooms
Edible Bites Episode 7: Oregon Psilocybin Services Act, Measure 109 Overview and Licensure
Minor Cannabinoids: Exploring the Science, Legality, & Opportunities
The Briefing by the IP Law Blog: Navigating the Hazy Intersection of Cannabis Law & Trademarks
Edible Bites Episode 1: Cannabis and Life Sciences Video Webinar Series
A history of the decline and rise of the marijuana empire
Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking - Diagnosing Health Care Podcast
In 2018, Congress passed the “Farm Bill” amending the Controlled Substances Act to remove hemp and hemp seeds from the federal definition of marijuana, a Schedule I controlled substance....more
Amid increasing investor interest in the telehealth sector, a recent Department of Justice (“DOJ”) prosecution involving Done Global underscores evolving enforcement risks for telehealth platforms, management services...more
On December 31, 2025, the federal Drug Enforcement Administration (DEA) extended current regulatory flexibilities related to tele-prescribing of controlled substances for another year. The DEA issued a fourth temporary...more
In a monumental decision almost five years in the making, the Alabama Medical Cannabis Commission on Thursday issued medical cannabis dispensary licenses to three applicants: GP6 Wellness LLC, RJK Holdings LLC and CCS of...more
The U.S. Drug Enforcement Administration (DEA), jointly with the U.S. Department of Health and Human Services (HHS), issued a fourth temporary rule extending the full set of COVID‑19 telemedicine flexibilities for prescribing...more
Recent regulatory actions by the Centers for Medicare and Medicaid Services (CMS), the US Drug Enforcement Administration (DEA), and the US Department of Health and Human Services (HHS) highlight heightened federal scrutiny...more
In my November 2025 blog post, I discussed the uncertainty surrounding the DEA’s then-pending telemedicine rule and its implications for ketamine clinics. At that time, the future of pandemic-era telehealth prescribing...more
On December 18, 2025, President Trump issued an executive order, "Increasing Medical Marijuana and Cannabidiol Research." While the order signals a significant federal shift toward expanded research access and a more coherent...more
The legal landscape for workplace drug testing is likely to see some significant changes in 2026. This article summarizes the shifts in federal and state policy, continuing and emerging challenges for employers, and what...more
Trending in Telehealth highlights monthly state legislative and regulatory developments that impact healthcare providers, telehealth and digital health companies, pharmacists, and technology companies that deliver and...more
The end of 2025 saw several notable developments for the telehealth industry with early 2026 poised to potentially challenge the industry with the impending expiration of the short-term extension of the Medicare telehealth...more
The Ohio Board of Pharmacy (“Board”) released new guidance identifying 10 common violations in prescriber clinics and medical spas. This guidance follows a recent surge in summary suspensions of Terminal Distributor of...more
Perhaps you’ve seen the headlines and perhaps you’re intrigued. Alabama physicians appear to be on the precipice of certifying patients to obtain medical cannabis for certain qualifying conditions....more
The Czech Republic (Czechia) will give its new adult-use cannabis law full effect on January 1, 2026, marking the culmination of three decades of reform from decriminalization to medical and now adult use. Czechia has...more
The regulatory landscape for substance use disorder (SUD) treatment records is changing—and the impact will extend far beyond traditional addiction treatment programs. With treatment options for SUD limited, some providers...more
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit....more
Welcome back to The Year In Weed, The Blunt Truth’s annual roundup of cannabis-related stories. As usual, I’ll adopt Dave Barry’s Year in Review format and look at stories month by month. Last year, I predicted that...more
President Donald Trump issued an executive order on December 18, 2025, directing the Department of Justice to expedite a rule to reclassify marijuana from a Schedule I drug to Schedule III — alongside less dangerous drugs...more
Subscription Based Telehealth Companies Indicted in Alleged $100 Million Prescription Drug Distribution Scheme - On December 17, Done Global, a San Francisco-based telehealth provider, and Mindful Mental Wellness PA (MMW),...more
In this collaborative analysis, Vicente LLP and the preeminent FDA law firm Kleinfeld, Kaplan & Becker LLP examine how the potential reclassification of cannabis into Schedule III could impact its distribution and dispensing....more
President Donald Trump issued the “Increasing Medical Marijuana and Cannabidiol Research” Executive Order (EO) on Dec. 18, 2025. Contrary to what has been reported by many news outlets, the EO does not, by itself, reschedule...more
On Dec. 18th, President Trump signed an executive order today directing the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act. ...more
When colleges are working with students or employees who are facing substance use concerns, one of the most common questions Behavioral Intervention Teams (BITs) encounter is: Can we objectively assess substance use? The...more
The manner in which services are provided via telehealth has the potential to look very different for healthcare providers—particularly those providing services to Medicare patients—in 2026. As 2025 draws to a close, the...more
This morning, the Alabama Medical Cannabis Commission voted unanimously to issue dispensary licenses to four applicants. Absent a stay entered by a court or the commission, three of those licenses will be issued on January 8,...more